Concepedia

Publication | Open Access

Switching from reference infliximab to CT-P13 in patients with inflammatory bowel disease: 12 months results

DOIFull Paper Access

42

Citations

20

References

2017

Year

Federico Argüelles‐Arias, María Fernanda Guerra Veloz, Raúl Perea Amarillo, Ángel Vilches‐Arenas, Luisa Castro Laria, Belén Maldonado Pérez, Dina Chaaro Benallal, A. Benítez Roldán, Vicente López Merino, Gabriel Ramírez,
European Journal of Gastroenterology & Hepatology

Abstract

Switching from infliximab RP to CT-P13 is efficacious and well tolerated in patients with CD or UC for up to 12 months.

References

YearCitations

Page 1